Sec62/Ki67 dual staining in cervical cytology specimens: a new marker for high-grade dysplasia

[1] Parkin DM(1984)Estimates of the worldwide frequency of twelve major cancers Bull World Health Organ 62 163-182

[2] Stjernswärd J(1987)Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes Lancet 329 1247-1249

[3] Muir CS(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 359-386

[4] Laara E(2000)Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 810-819

[5] Day N(1998)Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia Pathol Int 48 580-585

[6] Hakama M(2011)p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology Cancer Cytopathol 119 158-166

[7] Ferlay J(2011)Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology Gynecol Oncol 121 505-509

[8] Soerjomataram I(2015)Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results Cancer Cytopathol 123 373-381

[9] Dikshit R(2006)Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology Cancer Cytopathol 108 324-330

[10] Eser S(2017)Immunocytoexpression profile of ProExC in smears interpreted as ASC-US, ASC-H, and cervical intraepithelial lesion J Cytol 34 34-38

[1] Parkin DM(1984)Estimates of the worldwide frequency of twelve major cancers Bull World Health Organ 62 163-182

[2] Stjernswärd J(1987)Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes Lancet 329 1247-1249

[3] Muir CS(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 359-386

[4] Laara E(2000)Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 810-819

[5] Day N(1998)Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia Pathol Int 48 580-585

[6] Hakama M(2011)p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology Cancer Cytopathol 119 158-166

[7] Ferlay J(2011)Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology Gynecol Oncol 121 505-509

[8] Soerjomataram I(2015)Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results Cancer Cytopathol 123 373-381

[9] Dikshit R(2006)Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology Cancer Cytopathol 108 324-330

[10] Eser S(2017)Immunocytoexpression profile of ProExC in smears interpreted as ASC-US, ASC-H, and cervical intraepithelial lesion J Cytol 34 34-38